Stockscreener 앱 받기
3.31
0.90%
-0.03
시간 외 거래:
3.33
0.02
+0.60%
Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스
Faruqi & Faruqi Investigates Aquestive Therapeutics After 40% Stock Plunge Due to FDA Concerns - Intellectia AI
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - PR Newswire
Shorts Report: Is Aquestive Therapeutics Inc backed by strong institutional buyingQuarterly Investment Review & Verified Technical Trade Signals - baoquankhu1.vn
Kaplan Fox & Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations - NewMediaWire
About Us - FinancialContent
Peering Into Aquestive Therapeutics Inc's Recent Short Interest - Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc.AQST - PR Newswire
A Look At Aquestive Therapeutics (AQST) Valuation After Anaphylm Regulatory Update And FDA Feedback - Sahm
Commonwealth Equity Services LLC Takes $5.92 Million Position in Aquestive Therapeutics, Inc. $AQST - MarketBeat
Rate Hike: Is Aquestive Therapeutics Inc gaining market share2025 Price Momentum & Low Drawdown Trading Strategies - baoquankhu1.vn
Levi & Korsinsky Investigates Possible Securities Fraud by Aquestive Therapeutics, Inc. (AQST) - marketscreener.com
Here's Why Aquestive Therapeutics (AQST) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Trend Review: How does Aquestive Therapeutics Inc score in quality rankingsJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - baoquankhu1.vn
User - FinancialContent
Aquestive Therapeutics Inc. (AQST) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aquestive Therapeutics Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation - TradingView — Track All Markets
Aquestive drops as FDA flags issues in Anaphylm marketing application - MSN
Aquestive Therapeutics: Anaphylm Will Probably Survive This Regulatory Hurdle - Seeking Alpha
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - marketscreener.com
Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround - Your Wyoming Link
Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies in Anaphylm FilingWhat's Changed - Sahm
Assessing Aquestive Therapeutics (AQST) Valuation After FDA Flags Anaphylm Application Deficiencies - Yahoo Finance
Oklo, Applied Digital, Opendoor Technologies, Vistra, Aquestive Therapeutics: Stocks making the biggest moves today - MSN
Why Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies In Anaphylm Application – And What's Next - Yahoo Finance
Benzinga Bulls And Bears: Chevron, Palantir, Aquestive — And Real Estate Stocks Plummet - Benzinga
AQST Stock Plunges On An FDA Setback For Its Allergy Drug – Here’s What Has Changed - Stocktwits
Sector Update: Health Care - MarketScreener
Aquestive Therapeutics Stock Dips Amid Financial Challenges - StocksToTrade
Oklo, Applied Digital, Opendoor Technologies, Vistra, Aquestive Therapeutics: Stocks Making The Biggest Moves Today - Stocktwits
INVESTOR ALERT: Investigation of Aquestive Therapeutics, Inc. (AQST) by Holzer & Holzer, LLC - GlobeNewswire
Is Aquestive Therapeutics Inc. stock oversold or undervalued2025 Price Targets & Accurate Entry and Exit Point Alerts - ulpravda.ru
What's Going On With ARS Pharmaceuticals Stock Friday?ARS Pharmaceuticals (NASDAQ:SPRY) - Benzinga
Bad News For Competitor Turns Into Big Win For ARS Pharma Stock - Sahm
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Aquestive Therapeutics Sees Unusually Large Options Volume (NASDAQ:AQST) - MarketBeat
FDA Identifies NDA Deficiencies for Anaphylm as Review Continues, Aquestive Therapeutics Announces - Patient Care Online
BREAKING: Aquestive Therapeutics Investigated for Securities Fraud After FDA Identifies ... - Bluefield Daily Telegraph
BREAKING: Aquestive Therapeutics Investigated for Securities Fraud After FDA Identifies Deficiencies; Investors Should Contact Block & Leviton To Potentially Recover Losses - GlobeNewswire
Aquestive Therapeutics Faces Turbulent Market While Strategizing for Future Growth - timothysykes.com
FDA identifies deficiencies in Aquestive’s Anaphylm application By Investing.com - Investing.com Nigeria
FDA setback for Aquestive Thera’s Anaphylm - The Pharma Letter
Aquestive Therapeutics Stock (AQST) Opinions on FDA Deficiency Notice - Quiver Quantitative
Aquestive announces FDA identified deficiencies in NDA for Anaphylm - TipRanks
Why Is Aquestive Therapeutics Stock (AQST) Down Today? - TipRanks
Aquestive stock falls after FDA cites deficiencies in Anaphylm application By Investing.com - Investing.com South Africa
1.30%
1.45%
자본화:
|
볼륨(24시간):